Publications by authors named "Kabamba B Alexandre"

Claim this Profile
A
Aerosolized mRNA monoclonal antibodies: A new frontier in passive immunization for neonatal foals.
Kabamba Bankoledi Alexandre, Hazel Tumelo Mufhandu

Mol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lobostemon trigonus (Thunb.) H. Buek, a medicinal plant from South Africa as a potential natural microbicide against HIV-1.
Phindiwe Chawuke, Narine van den Berg, Gerda Fouche, Vinesh Maharaj, Tinotenda Shoko, Kabamba Bankoledi Alexandre

J Ethnopharmacol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress and Perspectives on HIV-1 microbicide development.
Kabamba B Alexandre, Hazel T Mufhandu, Grace M London, E Chakauya, M Khati

Virology· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UCLA1 aptamer inhibition of human immunodeficiency virus type 1 subtype C primary isolates in macrophages and selection of resistance.
Hazel Tumelo Mufhandu, Kabamba Bankoledi Alexandre, Elin Solomonovna Gray, Lynn Morris, Makobetsa Khati

Biochem Biophys Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus.
Tinoush Moulaei, Kabamba B Alexandre, Shilpa R Shenoy, Joel R Meyerson, Lauren Rh Krumpe

Retrovirology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.
Kabamba B Alexandre, Penny L Moore, Molati Nonyane, Elin S Gray, Nthabeleng Ranchobe

Virology· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C.
Hazel T Mufhandu, Elin S Gray, Maphuti C Madiga, Nancy Tumba, Kabamba B Alexandre

J Virol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.
Kabamba B Alexandre, Elin S Gray, Hazel Mufhandu, James B McMahon, Ereck Chakauya

Virology· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site.
Kabamba Bankoledi Alexandre, Elin S Gray, Ralph Pantophlet, Penny L Moore, James B McMahon

J Virol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin.
Kabamba B Alexandre, Elin S Gray, Bronwen E Lambson, Penny L Moore, Isaac A Choge

Virology· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis